We firstly evaluated the in vitro anti-tumor activity of PMI, CtrlPMI-Au SNH and PMI-Au SNH against three cell lines carrying wild-type p53 and overexpressed MDM2: HCT116 (colon), A375 (melanoma) and MCF-7 (breast). Here, MDM2 is linked to melanoma.